2018
DOI: 10.1038/s41591-018-0107-6
|View full text |Cite
|
Sign up to set email alerts
|

Clinically applicable deep learning for diagnosis and referral in retinal disease

Abstract: The volume and complexity of diagnostic imaging is increasing at a pace faster than the availability of human expertise to interpret it. Artificial intelligence has shown great promise in classifying two-dimensional photographs of some common diseases and typically relies on databases of millions of annotated images. Until now, the challenge of reaching the performance of expert clinicians in a real-world clinical pathway with three-dimensional diagnostic scans has remained unsolved. Here, we apply a novel dee… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
1,260
1
18

Year Published

2018
2018
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,899 publications
(1,285 citation statements)
references
References 37 publications
6
1,260
1
18
Order By: Relevance
“…An exception was a recent study that addressed the long‐term compliance of patients to wear a smartwatch, a body‐worn sensor, and a smartphone; in this study, a helpdesk to support patients proved a critical strategy to improve adherence . Another pitfall is the aspirational development of mobile health technologies as fulfilling diagnostic needs . Although technologies can be harnessed for validating patient‐centered outcomes and for supporting a clinical diagnosis, they remain inadequate as stand‐alone measures for “diagnostic accuracy.” Aiming at fulfilling this goal perpetuates the concept that the many molecular subtypes subsumed within the clinical diagnosis of PD can be unified by an ideal set of behavioral features.…”
Section: Current Gaps In the Use Of Mobile Health Technologiesmentioning
confidence: 97%
“…An exception was a recent study that addressed the long‐term compliance of patients to wear a smartwatch, a body‐worn sensor, and a smartphone; in this study, a helpdesk to support patients proved a critical strategy to improve adherence . Another pitfall is the aspirational development of mobile health technologies as fulfilling diagnostic needs . Although technologies can be harnessed for validating patient‐centered outcomes and for supporting a clinical diagnosis, they remain inadequate as stand‐alone measures for “diagnostic accuracy.” Aiming at fulfilling this goal perpetuates the concept that the many molecular subtypes subsumed within the clinical diagnosis of PD can be unified by an ideal set of behavioral features.…”
Section: Current Gaps In the Use Of Mobile Health Technologiesmentioning
confidence: 97%
“…Microsoft’s InnerEye offers a graphical user interface to algorithms that help radiologists diagnose cancerous tumours and plan precise surgical interventions 8. DeepMind Health recently partnered with Moorfields Eye Hospital to develop models for diagnosing common retinal pathologies based on optical coherence tomography scans 9. IBM’s Watson for Oncology seeks to provide personalised cancer care based on health records,10 although the project has run into numerous procurement problems, cost over-runs, and delays 11…”
Section: Predictions Versus Explanationsmentioning
confidence: 99%
“…In medical imaging, for example, ML may revolutionize identification of clinical signs, using pattern recognition to predict likely diagnosis or referrals. Evaluation is showing performance accuracy equaling human experts but at much faster speeds (De Fauw et al, ; Rajpurkar et al, ). As well as automating stages of diagnosis, ML may expand our current definitions of diseases and their subtypes.…”
mentioning
confidence: 99%